Photo: Courtesy of Teva
US-based biopharmaceutical company Arena Pharmaceuticals and Eisai, a drugs company based in Japan, have filed a complaint against Teva for patent infringement over a weight-loss generic drug.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Teva, ANDA, patent, FDA, Arena, Eisai, weight management, generic, patent infringement,